Apollomics (NASDAQ: APLM)
$0.45
(-4.5%)
-$0.02
Price as of April 26, 2024, 3:59 p.m. ET
Apollomics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Apollomics Company Info
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
News & Analysis
Featured Article
Why Shares of Apollomics Are Up Friday
The company just went public in March and recently received coverage and a buy rating from an analyst.
Jim Halley | Jun 2, 2023
Featured Article
Why Shares of Apollomics Soared in March
The company's shares jumped after it went public via a SPAC merger at the end of the month.
Jim Halley | Apr 6, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.